Current Month
Article Features
  3D Imaging and Computer Modeling Capture Breast Duct Development
Bad Habits That Lead to Cancer, Chronic Disease, Corrected by Simple Lifestyle Intervention
Breast Cancer Studies Ignore Race, Socioeconomic Factors
'Embattled' Breast Cancer Drugs Could Be Revived by New Discovery
First Study of Neoadjuvant Use of PARP Inhibitor Shows Promise for Early-Stage BRCA+ Breast Cancer Patients
Greater Levels of Vitamin D Associated with Decreasing Risk of Breast Cancer
Higher Body Fat Linked to Lower Breast Cancer Risk in Younger Women
Landmark Study Finds More Breast Cancer Patients Can Safely Forgo Chemotherapy
Laser-Sonic Scanner Aims to Replace Mammograms for Finding Breast Cancer
'Lipofilling' Technique Found Safe for Reconstruction After Breast Cancer Surgery
Machine Learning Helps Detect Lymphedema Among Breast Cancer Survivors
More Breast Cancers Found with Combined Digital Screening
Mozart, Meditation and a Yoga Mat: Oncologists Welcome Integrative Therapies for Breast Cancer
New Approach to Immunotherapy Leads to Complete Response in Breast Cancer Patient
New Study Confirms Higher Cancer Rate in Women with Dense Breast Tissue
Putting the Brakes on Metastatic Cancer
Study Explores Satisfaction, Quality of Life After Breast Reconstruction
Targeting the Engine Room of the Cancer Cell
U.S. Flight Attendants at Elevated Risk of Several Forms of Cancer

Landmark Study Finds More Breast Cancer Patients Can Safely Forgo Chemotherapy

A 21-gene test performed on tumors could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study published in the New England Journal of Medicine.

Loyola Medicine oncologist Kathy Albain, MD, is among the main co-authors of the study and a member of the clinical trial's steering committee. First author is Joseph Sparano, MD, of Montefiore Medical Center in Bronx, NY. The study was published in conjunction with its presentation at the plenary session of the American Society of Clinical Oncology 2018 annual meeting in Chicago.

"With results of this groundbreaking study, we now can safely avoid chemotherapy in about 70 percent of patients who are diagnosed with the most common form of breast cancer," Albain said. "For countless women and their doctors, the days of uncertainty are over."

Albain, the Huizenga Family Endowed Chair in Oncology Research at Loyola University Chicago Stritch School of Medicine, has conducted research with the 21-gene test and also used it in her practice for years.

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon